PF-739
CAS No. 1852452-14-2
PF-739 ( PF 739;PF739 )
Catalog No. M12861 CAS No. 1852452-14-2
A novel potent, pan-AMPK activator with similar potency for all AMPK heterotrimers.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 963 | Get Quote |
|
50MG | 1962 | Get Quote |
|
100MG | 2520 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePF-739
-
NoteResearch use only, not for human use.
-
Brief DescriptionA novel potent, pan-AMPK activator with similar potency for all AMPK heterotrimers.
-
DescriptionA novel potent, pan-AMPK activator with similar potency for all AMPK heterotrimers; increases the phosphorylation of the AMPK substrate ACC at S79 with EC50 of 121 nM, potently inhibits de novo lipogenesis (IC50=25 nM) in primary rat hepatocytes; increases PGC1a transcription and mitochondrial content, effectively activats AMPK in hepatocytes and in skeletal muscle; caused a rapid lowering of plasma glucose levels with no impact on hepatic glucose production in diabetic mice.
-
SynonymsPF 739;PF739
-
PathwayMembrane Transporter/Ion Channel
-
TargetAMPK
-
RecptorAMPK
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1852452-14-2
-
Formula Weight442.90
-
Molecular FormulaC23H23ClN2O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESO[C@H]1[C@](OC[C@H]2OC3=NC4=CC(C5=CC=C(C6(CO)CC6)C=C5)=C(Cl)C=C4N3)([H])[C@]2([H])OC1
-
Chemical Name(3R,3aR,6R,6aR)-6-((6-chloro-5-(4-(1-(hydroxymethyl)cyclopropyl)phenyl)-1Hbenzo[d]imidazol-2-yl)oxy)hexahydrofuro[3,2-b]furan-3-ol
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Cokorinos EC, et al. Cell Metab. 2017 May 2;25(5):1147-1159.
molnova catalog
related products
-
Buformin hydrochlori...
Buformin hydrochloride is a potent AMPK activator,an oral antidiabetic drug of the biguanide class.
-
WZ4003
WZ4003 is a highly specific NUAK kinase inhibitor with IC50 of 20 nM and 100 nM for NUAK1 and NUAK2, respectively.
-
BC1618
BC1618 is an orally active Fbxo48 inhibitory compound, stimulates Ampk-dependent signaling.